Suita, Japan

Shuichi Hanada

This inventor holds 1 USPTO granted patent. Top assignee: The Green Cross Company. Active years: 1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shuichi Hanada. Retrieved from https://idiyas.com/inventor/shuichi-hanada-8ri3t6cg

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1989

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shuichi Hanada: Innovator in Anti-Inflammatory Research

Introduction

Shuichi Hanada is a notable inventor based in Suita, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory agents. His work focuses on creating compounds that offer therapeutic benefits with reduced side effects.

Latest Patents

Hanada holds a patent for indoleacetic acid derivatives used as anti-inflammatories. The specific compound, 1-(fluoro- or perfluoro lower alkyl-substituted benzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid carboxymethyl ester, has been found to exhibit anti-inflammatory and analgesic activity. This compound is particularly noteworthy for having fewer gastrointestinal side effects compared to its homologues, acematacin and indometacin.

Career Highlights

Shuichi Hanada is associated with The Green Cross Company, where he continues to advance his research in medicinal chemistry. His innovative approach to drug development has positioned him as a key figure in the pharmaceutical industry.

Collaborations

Hanada has collaborated with notable colleagues, including Chikara Fukaya and Youichiro Naito. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic agents.

Conclusion

Shuichi Hanada's contributions to anti-inflammatory research exemplify the impact of innovative thinking in pharmaceuticals. His work not only advances medical science but also improves patient care through the development of safer therapeutic options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…